Cordyceps Sunshine Biotech Holdings (RAJAF) Receivables - Net (2021)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Receivables - Net of $224097.0 in Q4 2021.

Cordyceps Sunshine Biotech Holdings (RAJAF) Receivables - Net (2021) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Receivables - Net history runs 1 years deep, the most recent figure standing at $224097.0 for Q4 2021.

  • In Q4 2021, Receivables - Net changed N/A year-over-year to $224097.0; the TTM figure through Dec 2021 stood at $224097.0 (changed N/A YoY), while the FY2022 annual figure was $149510.0, down 33.28% from the prior year.
  • Receivables - Net was $224097.0 for Q4 2021 at Cordyceps Sunshine Biotech Holdings.
  • In the past five years, Receivables - Net ranged from a high of $224097.0 in Q4 2021 to a low of $224097.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Paranovus Entertainment Technology 12,507.92 Bn 12,507.92 Bn -
2 Kraft Heinz 27.05 Bn 22.98 Bn 2.22 Bn
3 General Mills 17.93 Bn 17.16 Bn 1.37 Bn
4 Jbs 13.56 Bn 8.99 Bn 2.32 Bn
5 Hormel Foods 13.29 Bn 12.44 Bn 518.51 Mn
6 Mccormick 12.45 Bn 12.85 Bn 708.90 Mn
7 Magnum Ice Cream 11.94 Bn 11.47 Bn -
8 J M Smucker 11.83 Bn 11.77 Bn 862.10 Mn
9 Smithfield Foods 9.80 Bn 8.73 Bn 511.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 224,097.00
Dec 31, 2021 224,097.00